Abstract | PURPOSE: METHODS: This was a 4 week, randomized, parallel-group, single-center, active-controlled study. One group of patients received postoperative topical EPP while the other group received postoperative topical PF. Both medications were dosed 4 times per day for 14 days and then BID until the container was empty. Both groups of patients received diclofenac sodium QID for 14 days and hydroxypropyl guar (HP-Guar, Systane) QID for 7 days then PRN (or as directed). The presence of corneal surface keratitis, anterior chamber cells and flare (scales 0-3 for keratitis, 0-5 for cells and 0-4 for flare; 0 = none) was evaluated by slit lamp biomicroscopy. RESULTS: EPP produced significantly lower (P < 0.05) anterior chamber flare scores 14 days following surgery (mean +/- SD: 0.86 +/- 0.53) than PF (1.08 +/- 0.40). Otherwise, there were no differences observed between the 2 treatments with respect to keratitis, anterior chamber flare or cells at postop days 1, 7, or 28. CONCLUSIONS: This comparative trial demonstrated that both formulations of prednisolone acetate 1% have similar efficacy in the treatment of postoperative ophthalmologic inflammation.
|
Authors | Johnny L Gayton |
Journal | Current medical research and opinion
(Curr Med Res Opin)
Vol. 21
Issue 8
Pg. 1291-5
(Aug 2005)
ISSN: 0300-7995 [Print] England |
PMID | 16083539
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glucocorticoids
- prednisolone acetate
- Prednisolone
|
Topics |
- Aged
- Cataract Extraction
(adverse effects)
- Female
- Glucocorticoids
(therapeutic use)
- Humans
- Inflammation
(etiology, prevention & control)
- Lens Implantation, Intraocular
(adverse effects)
- Macular Edema
(etiology, prevention & control)
- Male
- Postoperative Care
- Prednisolone
(analogs & derivatives, therapeutic use)
- Treatment Outcome
|